mark kris

  • 20140419_KRIS
    April 19, 2014  

    There was word this week of what is being described as a pioneering clinical trial being done in the U.K. for patients with advanced lung cancer. What’s so novel about this development?Hari Sreenivasan spoke to Dr. Mark Kris, an oncologist at Memorial Sloan Kettering Cancer Center, about what makes this clinical trial so interesting. Continue reading